When it comes to clinical trials, participants and potential ‘subjects’ have more control than they think.
BY the time S. Kamakshi, with the support of her husband H. Subramaniam, first volunteered to participate in a clinical trial involving an experimental drug for chronic myeloid leukaemia (CML) in the year 2000, eight years had already passed since the day she first heard she had the disease.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
